ANTIBODY FOR CELIAC DISEASE - ANVISA Registration 10339840235

Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10339840235 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10339840235
Registration Details
ANVISA Registration Number: 10339840235
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

LIAISON tTG IgA CONTROL
Risk Class II

Registration Details

10339840235

25351070379200660

01896764000170

Company Information

Italy
PT: ITÁLIA

Dates and Status

May 29, 2006

VIGENTE

09/18/2025 19:00:01